Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-dawn
/
Day One Biopharmaceuticals Inc
DAWN
Add to Watchlist
21.530
USD
0.000
0.00%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
2.22B
Market Cap
Loss
P/E TTM
Day One Biopharmaceuticals Inc
21.530
0.000
0.00%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
6.44%
Atlas Venture
6.21%
Glazer Capital, LLC
5.43%
Vestal Point Capital, LP
5.03%
State Street Investment Management (US)
4.15%
Other
72.74%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
6.44%
Atlas Venture
6.21%
Glazer Capital, LLC
5.43%
Vestal Point Capital, LP
5.03%
State Street Investment Management (US)
4.15%
Other
72.74%
Shareholder Types
Shareholders
Proportion
Investment Advisor
28.12%
Hedge Fund
22.15%
Investment Advisor/Hedge Fund
19.20%
Venture Capital
6.62%
Research Firm
5.50%
Individual Investor
3.51%
Private Equity
0.53%
Bank and Trust
0.41%
Sovereign Wealth Fund
0.36%
Other
13.60%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
425
86.73M
83.94%
-36.20M
2025Q4
390
86.52M
115.65%
+81.15K
2025Q3
401
86.44M
119.83%
-942.76K
2025Q2
390
87.37M
118.27%
-8.42M
2025Q1
389
95.92M
111.30%
-16.89M
2024Q4
373
95.70M
104.59%
+1.59M
2024Q3
359
93.92M
88.75%
+17.37M
2024Q2
339
76.41M
96.74%
+2.06M
2024Q1
320
74.24M
101.26%
-14.24M
2023Q4
310
78.10M
98.05%
-1.14M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
6.65M
6.44%
+222.57K
+3.46%
Dec 31, 2025
Atlas Venture
6.41M
6.21%
-17.70K
-0.28%
Dec 31, 2025
Glazer Capital, LLC
5.62M
5.44%
+5.62M
--
Mar 12, 2026
Vestal Point Capital, LP
5.20M
5.03%
+2.52M
+94.39%
Dec 31, 2025
State Street Investment Management (US)
4.29M
4.15%
+1.05M
+32.38%
Dec 31, 2025
Deerfield Management Company, L.P.
3.72M
3.6%
-982.28K
-20.88%
Dec 31, 2025
Fidelity Management & Research Company LLC
3.46M
3.35%
-4.15M
-54.56%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Products ETF
1.78%
ALPS Medical Breakthroughs ETF
0.32%
State Street SPDR S&P Biotech ETF
0.23%
Direxion Daily S&P Biotech Bull 3X Shares
0.14%
WisdomTree US SmallCap Fund
0.12%
ProShares Ultra Nasdaq Biotechnology
0.12%
Invesco Nasdaq Biotechnology ETF
0.08%
Fidelity Fundamental Small-Mid Cap ETF
0.07%
iShares Biotechnology ETF
0.05%
Pacer WealthShield ETF
0.04%
View more
Virtus LifeSci Biotech Products ETF
Proportion
1.78%
ALPS Medical Breakthroughs ETF
Proportion
0.32%
State Street SPDR S&P Biotech ETF
Proportion
0.23%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion
0.14%
WisdomTree US SmallCap Fund
Proportion
0.12%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.12%
Invesco Nasdaq Biotechnology ETF
Proportion
0.08%
Fidelity Fundamental Small-Mid Cap ETF
Proportion
0.07%
iShares Biotechnology ETF
Proportion
0.05%
Pacer WealthShield ETF
Proportion
0.04%